Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

FELE vs BMI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

BMI Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 6–4 Matrix Metrics)

BMI Overall Winner 6-Pillar Tally: FELE 3 – 3 BMI Matrix Metrics: FELE 4 – 6 BMI

As of Nov 17, 2026, Badger Meter, Inc. (BMI) is the stronger overall head-to-head candidate over Franklin Electric Co Inc (FELE) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Options & Positioning, R&D & Supply-Chain Moat). FELE carries a Unified Composite Score of 42.0/100 (HOLD) at $96.56 (17.9x Forward P/E, 12.9% operating margin), whereas BMI carries 45.6/100 (HOLD) at $154.25 (31.9x Forward P/E, 18.8% operating margin).

  • Technical & Structure Timing Caution: FELE is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 45.8); meanwhile BMI trades in a Markup technical trend (SURGE options phase, RSI 55.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About FELE vs BMI
FELE NASDAQ
Franklin Electric Co Inc
Motors & Generators
$96.56
-0.27% 1D
Market Cap $4.3B
TTM Revenue $2.26B
Forward P/E 17.9x
Beta / 30D Vol 0.73β · 30% Vol
Unified Composite Score
42.0 / 100 HOLD
Tech 44.0 Fund 48.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -1.8%) with fading momentum, RSI 46
RSI-14: 45.8 · SMA20: $97.93 · SMA50: $97.73
BMI NYSE Head-to-Head Winner
Badger Meter, Inc.
Totalizing Fluid Meters & Counting Devices
$154.25
-3.13% 1D
Market Cap $4.5B
TTM Revenue $881M
Forward P/E 31.9x
Beta / 30D Vol 0.50β · 66% Vol
Unified Composite Score
45.6 / 100 HOLD
Tech 30.0 Fund 43.0 Flow 56.0 Mom 41.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (6.4% over 20 days), RSI 56
RSI-14: 55.7 · SMA20: $153.59 · SMA50: $138.25

6-Pillar Scorecard Institutional Category Breakdown (FELE 3 – 3 BMI)

Columns: Metric · FELE · BMI
1. Valuation Multiples FELE
Forward P/E 17.9x 31.9x
Trailing P/E 22.1x 35.7x
PEG Ratio 1.50x 3.68x
EV / Revenue 1.9x 5.1x
2. Growth & Scale FELE
Revenue Growth (YoY) +8.9% +0.1%
Earnings Growth (YoY) +264.9% +4.2%
TTM Revenue (USD) $2.26B $881M
Market Cap $4.3B $4.5B
3. Profitability & Quality BMI
Gross Margin 35.4% 41.6%
Operating Margin 12.9% 18.8%
Net Profit Margin 8.8% 14.4%
Return on Equity (ROE) 14.5% 18.7%
4. Balance Sheet & Cash Flow FELE
Cash Generation (TTM) $362M EBITDA $142M
Cash Flow Margin 16.0% EBITDA Mgn 16.2%
Net Cash / Leverage $32.73 Book/Sh · 14.5% ROE $22.80 Book/Sh · 18.7% ROE
Dividend Yield 1.13% 1.07%
5. Options & Positioning BMI
Options Structure Phase UNCLASSIFIED SURGE
Current IV / %ile 25.0% (100th %ile) 41.4% (8th %ile)
Put/Call OI Skew N/A 4.97x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Markup
6. R&D & Supply-Chain Moat BMI
OpEx & R&D Intensity 22.5% of Rev ($509M) 22.8% of Rev ($201M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Specialty Industrial Machinery Operator Scientific & Technical Instruments Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: FELE (4) vs BMI (6)
Institutional Metric FELE BMI Criterion Row Edge
Market Capitalization
Scale
$4.3B $4.5B Larger Scale BMI
Trailing P/E Ratio
Valuation
22.1x 35.7x Lower Multiple FELE
Forward P/E Ratio
Valuation
17.9x 31.9x Lower Multiple FELE
Revenue Growth (YoY)
Growth
+8.9% +0.1% Higher Growth FELE
Operating Margin (TTM)
Profitability
12.9% 18.8% Higher Margin BMI
Net Profit Margin
Profitability
8.8% 14.4% Higher Margin BMI
Return on Equity (ROE)
Capital Efficiency
14.5% 18.7% Higher ROE BMI
52-Week Range Position
Momentum
27% ($90–$116) 56% ($112–$187) Stronger Trend BMI
Beta / 30D Volatility
Risk Regime
0.73β · 30% Vol 0.50β · 66% Vol Lower Realized Risk FELE
Unified Institutional Score
Composite Signal
42.0 / 100 (HOLD) 45.6 / 100 (HOLD) Higher Composite BMI
Trailing 12M Revenue (USD)
Operating Scale
$2.26B $881M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
35.4% 41.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.50x PEG · 1.9x EV/Rev 3.68x PEG · 5.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$362M EBITDA ($32.73 Book/Sh · 14.5% ROE) $142M ($22.80 Book/Sh · 18.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BMI +25.05 pp
FELE: -2.88% · BMI: +22.17%
3M Horizon BMI +25.01 pp
FELE: -7.21% · BMI: +17.8%
6M Horizon BMI +28.23 pp
FELE: +1.22% · BMI: +29.45%
1Y Horizon FELE +16.02 pp
FELE: +3.71% · BMI: -12.31%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FELE vs BMI. Trailing 12-month operating profitability (FELE 12.9% vs BMI 18.8%) and valuation multiples (FELE 17.9x vs BMI 31.9x Forward P/E) are benchmarked directly in Pillar 4 below.

FELE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.26B
Gross Margin35.4%
Op. Margin12.9%
ROE / Fwd P/E14.5% · 17.9x
BMI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$881M
Gross Margin41.6%
Op. Margin18.8%
ROE / Fwd P/E18.7% · 31.9x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
FELE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 25.0%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FELE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BMI SURGE
9d in phase · OBV NEUTRAL
Current IV 41.4%
IV Percentile 8th %ile
Put/Call OI Skew 4.97x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact BMI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
FELE Moat Profile Cyclical / Execution-Driven Positioning
Specialty Industrial Machinery Operator
Competes within the Specialty Industrial Machinery value chain with $4.3B market capitalization and 12.9% operating margin.
OpEx & R&D Reinvestment 22.5% of Rev ($509M)
90D Engineering Disclosures 0 Published
BMI Moat Profile Scale & Operating Efficiency Moat
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $4.5B market capitalization and 18.8% operating margin.
OpEx & R&D Reinvestment 22.8% of Rev ($201M)
90D Engineering Disclosures 0 Published

Investor FAQ FELE vs BMI Key Questions & Quantitative Answers

As of Nov 17, 2026, Badger Meter, Inc. (BMI) is the stronger overall head-to-head candidate over Franklin Electric Co Inc (FELE) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Options & Positioning, R&D & Supply-Chain Moat). FELE carries a Unified Composite Score of 42.0/100 (HOLD) at $96.56 (17.9x Forward P/E, 12.9% operating margin), whereas BMI carries 45.6/100 (HOLD) at $154.25 (31.9x Forward P/E, 18.8% operating margin). Technical & Structure Timing Caution: FELE is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 45.8); meanwhile BMI trades in a Markup technical trend (SURGE options phase, RSI 55.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

FELE leads the Growth & Scale pillar: FELE posts +8.9% YoY revenue growth and +264.9% YoY earnings growth on $2.26B TTM revenue (35.4% gross margin, 12.9% operating margin), compared with BMI at +0.1% YoY revenue growth and +4.2% YoY earnings growth on $881M TTM revenue (41.6% gross margin, 18.8% operating margin). On trailing 12-month operating scale, FELE generates $2.26B in USD-normalized revenue versus $881M for BMI. In operating R&D and SG&A reinvestment, FELE deploys 22.5% of Rev ($509M) (0 90-day corporate R&D disclosures) versus 22.8% of Rev ($201M) (0 disclosures) for BMI.

FELE screens cheaper on headline valuation multiples. FELE trades at 17.9x Forward P/E, 22.1x Trailing P/E, 1.50x PEG, and 1.9x EV/Revenue (16.0% EBITDA margin), whereas BMI trades at 31.9x Forward P/E, 35.7x Trailing P/E, 3.68x PEG, and 5.1x EV/Revenue (16.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FELE (14.5% ROE) versus BMI (18.7% ROE) capital efficiency.

In options market volatility and institutional positioning, FELE carries 25.0% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.73β · 30% Vol realized risk). By comparison, BMI carries 41.4% implied volatility (8th %ile, Compressed (<25th %ile)), a 4.97x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (0.50β · 66% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.